These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 20561344

  • 1. The impact of value-based benefit design on adherence to diabetes medications: a propensity score-weighted difference in difference evaluation.
    Zeng F, An JJ, Scully R, Barrington C, Patel BV, Nichol MB.
    Value Health; 2010; 13(6):846-52. PubMed ID: 20561344
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of increased adherence and cost savings of an employer value-based benefits program targeting generic antihyperlipidemic and antidiabetic medications.
    Clark B, DuChane J, Hou J, Rubinstein E, McMurray J, Duncan I.
    J Manag Care Pharm; 2014 Feb; 20(2):141-50. PubMed ID: 24456315
    [Abstract] [Full Text] [Related]

  • 3. Prescription co-pay reduction program for diabetic employees.
    Nair KV, Miller K, Park J, Allen RR, Saseen JJ, Biddle V.
    Popul Health Manag; 2010 Oct; 13(5):235-45. PubMed ID: 20879904
    [Abstract] [Full Text] [Related]

  • 4. Increasing copayments and adherence to diabetes, hypertension, and hyperlipidemic medications.
    Maciejewski ML, Bryson CL, Perkins M, Blough DK, Cunningham FE, Fortney JC, Krein SL, Stroupe KT, Sharp ND, Liu CF.
    Am J Manag Care; 2010 Jan 01; 16(1):e20-34. PubMed ID: 20059288
    [Abstract] [Full Text] [Related]

  • 5. Impact of a value-based formulary in three chronic disease cohorts.
    Yeung K, Basu A, Marcum ZA, Watkins JB, Sullivan SD.
    Am J Manag Care; 2017 Mar 01; 23(3 Suppl):S46-S53. PubMed ID: 29648740
    [Abstract] [Full Text] [Related]

  • 6. The impact of a value-based insurance design plus health coaching on medication adherence and medical spending.
    Musich S, Wang S, Hawkins K.
    Popul Health Manag; 2015 Jun 01; 18(3):151-8. PubMed ID: 25247449
    [Abstract] [Full Text] [Related]

  • 7. The effect of a large regional health plan's value-based insurance design program on statin use.
    Frank MB, Fendrick AM, He Y, Zbrozek A, Holtz N, Leung S, Chernew ME.
    Med Care; 2012 Nov 01; 50(11):934-9. PubMed ID: 23047782
    [Abstract] [Full Text] [Related]

  • 8. Economic and clinical impact of innovative pharmacy benefit designs in the management of diabetes pharmacotherapy.
    Berger J.
    Am J Manag Care; 2007 Apr 01; 13 Suppl 2():S55-8. PubMed ID: 17417934
    [Abstract] [Full Text] [Related]

  • 9. Part D coverage gap and adherence to diabetes medications.
    Gu Q, Zeng F, Patel BV, Tripoli LC.
    Am J Manag Care; 2010 Apr 01; 16(12):911-8. PubMed ID: 21348561
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cost, healthcare resource utilization, and adherence of individuals with diabetes using U-500 or U-100 insulin: a retrospective database analysis.
    Eby EL, Wang P, Curtis BH, Xie J, Haldane DC, Idris I, Peters AL, Hood RC, Jackson JA.
    J Med Econ; 2013 Apr 01; 16(4):529-38. PubMed ID: 23363330
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Economic outcomes of exenatide vs liraglutide in type 2 diabetes patients in the United States: results from a retrospective claims database analysis.
    Pelletier EM, Pawaskar M, Smith PJ, Best JH, Chapman RH.
    J Med Econ; 2012 Apr 01; 15(6):1039-50. PubMed ID: 22533526
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Impact of daily dosing frequency on adherence to chronic medications among nonvalvular atrial fibrillation patients.
    Laliberté F, Nelson WW, Lefebvre P, Schein JR, Rondeau-Leclaire J, Duh MS.
    Adv Ther; 2012 Aug 01; 29(8):675-90. PubMed ID: 22898791
    [Abstract] [Full Text] [Related]

  • 19. A retrospective database analysis of neuropathic pain and oral antidiabetic medication use and adherence among Texas adults with type 2 diabetes enrolled in Medicaid.
    Oladapo AO, Barner JC, Rascati KL, Strassels SA.
    Clin Ther; 2012 Mar 01; 34(3):605-13. PubMed ID: 22386828
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.